The goal of this activity is for learners to be better able to improve their ability to work collaboratively to optimize the treatment management and quality of care for patients with MM being treated with BCMA-directed therapies.
- Provider:Medscape, LLC
- Start Date: 2025-04-11 05:00:00
- End Date: 2025-04-11 05:00:00
- Credit Details: Pharmacy: 1.0 hours
- Commercial Support: Source: GlaxoSmithKline - Amount: 107890.0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 89909.0 - Is Kind Support: False Source: Regeneron Pharmaceuticals, Inc. - Amount: 71927.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest